Research on injectable oriented hydrogels for spinal cord repair

The research objective of Dr.-Ing. Laura De Laporte, junior group leader at DWI – Leibniz Institute for Interactive Materials in Aachen, is to develop a minimally invasive therapy for spinal cord injury. Her goal and her scientific approach to develop an injectable material with the ability to provide biochemical and physical guidance for regenerating nerves across the injury site, was selected by the European Research Council (ERC). Laura De Laporte now receives a 1.5 Million Euro ERC Starting Grant for her project ANISOGEL.

Dr.-Ing. Laura De Laporte receives an ERC Starting Grant.
Dr.-Ing. Laura De Laporte receives an ERC Starting Grant.
Source: Phatcharin Tha-in

Spinal cord injury affects approximately two million people worldwide and is devastating as it leads to a loss of motor and sensory function below the point of injury. Regenerative therapies therefore try to restore nerve tracts and their function. Human neural stem cells or oligodendrocytes, which form the myelin sheet around the nerve cells, have been successfully transplanted into the damaged area and have created a spark of hope. To support these transplanted and other native cells at the injury site, and to guide neuron growth across this area, scientists are also investigating nerve bridges that are made of biomaterials, provide functional domains, and release growths factors. Unfortunately, such implants still face the challenge to stimulate the growing nerves to cross the point of injury and reenter the healthy spinal cord to rebuild functional connections.

In her project ANISOGEL, Laura De Laporte will engineer an injectable biomaterial that can be used as a matrix for a minimally invasive therapy to support oriented regeneration of damaged nerves. The material is based on a soft, water-rich polymeric network (hydrogel), which gels in situ and can be designed to mimic the conditions of the natural cell environment. The physical, chemical, and biological properties of these gels can be tailored bottom-up to resemble the body’s own extracellular matrix that provides mechanical and biological support to the cells.

“A hydrogel-based approach is not new. The innovative aspect about ANISOGEL is that we want to synthesize a material that can be hierarchically structured and form an anisotropic architecture in situ,” explains De Laporte. “This will improve the cells’ spatial orientation, which is crucial for nerve repair. The hydrogel will be further modified with biological signaling molecules to create an environment that stimulates cellular processes necessary for spinal cord regeneration and to regain functionality.”


PROFILE:
Laura De Laporte received her Masters in Chemical Engineering at the University of Ghent and obtained her PhD in the laboratory of Prof. Lonnie Shea at Northwestern University in the United States. There, she focused on the development of multiple channel bridges with the ability for DNA and protein delivery for spinal cord repair. As a post-doctoral researcher at EPFL (Switzerland) in the laboratory of Prof. Jeffrey Hubbell, she engineered extracellular matrix-like hydrogels for tissue and nerve repair. She started her junior research group at DWI in October 2013. With the ERC Starting Grant, the European Research Council supports her work for the next five years.

Source: Press release DWI - Leibniz-Institut für Interaktive Materialien

17.03.2015

Read all latest stories

Related articles

Photo

Vascular PSP survey

Giving patients a say in vascular conditions research

A new survey will give patients, carers and members of the public the opportunity to have their say in what they think is important for future research for vascular conditions. The Vascular Priority…

Photo

High blood pressure

Hypertension: treatment disadvantage in the south

Healthcare in low- and middle-income countries is poorly prepared for the increasing number of people with high blood pressure, with more than two-thirds of people affected going without treatment…

Photo

Computational medicine

Using virtual populations to create safer medical devices

The current innovation process for medical technologies risks stifling the development of new devices, a leading researcher has argued. Alejandro Frangi, Professor of Computational Medicine at the…

Related products

Beckman Coulter – Remisol Advance

LIS, Middleware, POCT

Beckman Coulter – Remisol Advance

Beckman Coulter, Inc.
Eppendorf – Mastercycler nexus X2

Research Use Only (RUO)

Eppendorf – Mastercycler nexus X2

Eppendorf AG
Sarstedt – Low DNA Binding Micro Tubes

Research Use Only (RUO)

Sarstedt – Low DNA Binding Micro Tubes

SARSTEDT AG & CO. KG
Shimadzu – CLAM-2030

Research Use Only (RUO)

Shimadzu – CLAM-2030

Shimadzu Europa GmbH